4',5-Dihydroxy-Diclofenac

4',5-Dihydroxy-Diclofenac

SCHEMBL7162002

O=C(O)Cc1cc(O)ccc1Nc1c(Cl)cc(O)cc1Cl

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2A Q9UQM7 5/20 0.81
PTGS2 P35354 6/20 0.64
CXCL8 P10145 4/20 0.56
TTR P02766 2/20 0.56
ABCB11 O95342 2/20 0.56
PTGS1 P23219 2/20 0.56
NR1I3 Q14994 2/20 0.56
AKR1B10 O60218 1/20 0.56
UGT1A9 O60656 1/20 0.56
TRPA1 O75762 1/20 0.56
MT-CO2 P00403 1/20 0.56
ALB P02768 1/20 0.56
UGT1A6 P19224 1/20 0.56
UGT1A1 P22309 1/20 0.56
CXCR1 P25024 1/20 0.56
ADRA1A P35348 1/20 0.56
AGTR2 P50052 1/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
NR1H4 Q96RI1 1/20 0.56
UGT1A7 Q9HAW7 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
5-Hydroxy-Diclofenac SCHEMBL2738864 0.90 CAMK2A (1.00) CAMK2APTGS2CXCL8TTRABCB11
4'-Hydroxy-Diclofenac SCHEMBL155743 0.87 CAMK2A (1.00) CAMK2APTGS2CXCL8TTRABCB11
4'-Hydroxy-Diclofenac SCHEMBL30350150 0.87 CAMK2A (1.00) CAMK2APTGS2CXCL8TTRABCB11
SCHEMBL20034267 0.85 CAMK2A (0.64) CAMK2APTGS2CXCL8TTRABCB11
SCHEMBL23691080 0.85 TTR (0.62) CAMK2APTGS2CXCL8TTRABCB11
SCHEMBL1030170 0.81 PTGS2 (0.73) CAMK2APTGS2CXCL8TTRABCB11
SCHEMBL10801656 0.79 PTGS2 (0.61) CAMK2APTGS2CXCL8TTRABCB11
SCHEMBL1032535 0.79 PTGS2 (0.87) CAMK2APTGS2CXCL8TTRABCB11
4'-Hydroxy-Diclofenac SCHEMBL30753145 0.78 CAMK2A (0.63) CAMK2APTGS2CXCL8TTRABCB11
SCHEMBL2238912 0.77 CAMK2A (0.59) CAMK2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230642-A1 HYDROXYLATION TECHNIQUES HYPHA DISCOVERY LTD. (GB) 2021-07-29 US disclosed
US-6552077-B2 Kidney disorders EXOCELL, INC. 2003-04-22 US disclosed
US-6355680-B1 BLOCKING REACTION OF GLUCOSE AND ALBUMIN EXOCELL, INC. 2002-03-12 US disclosed
US-20010034359-A1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies EXOCELL, INC. 2001-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034359-A1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies ALB, AGER, TTR CAMK2A 2988/4885PTGS2 2067/4885CXCL8 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.